中山大便血热(中山肛门里面有个小肉球) (今日更新中)

President Donald Trump will welcome the United States' Winter Olympics teams to the White House Friday, but the list of potential absentees reads like a who's who list of America's most well-known athletes.Lindsey Vonn, Gus Kenworthy and Adam Rippon are among the stars set to be absent, some citing political differences with the president.Freestyle skier Kenworthy, a vocal Trump critic, tweeted "the resistance is real" in reference to the expected White House no-shows."All US Olympians and Paralympians are invited to visit the White House and meet the President after the Games," tweeted the American, whose kiss with boyfriend Matthew Wilkas in Pyeongchang, South Korea became worldwide news after it was broadcast live on national television."Today is this year's visit and USOC [US Olympic Committee] spokesperson says he's never seen so many athletes turn down their invites. The resistance is real."The US Olympic Committee has yet to respond to CNN's request for a comment on the numbers of predicted absentees. 1031

President Donald Trump’s physical Dr. Sean Conley confirmed Friday that the president is taking an experimental antibody treatment to help him fight the coronavirus following his diagnosis this morning.Dr. Conley said Friday afternoon that Trump is "fatigued."Trump is taking the Regeneron antibody cocktail, which is currently in a clinical trial. Conley said that Trump has been treated with a single 8 gram dose, which Conley said was infused "without incident."Trump is also said to be taking Vitamin D, zinc, famotidine, melatonin and daily aspirin. The Regeneron trial has only been tried on 275 patients as of this week, but the company said earlier this week that it has showed promising results.Regeneron confirmed that Trump was given the treatment under a "compassionate use request.""In the USA, this type of compassionate use program is also known as an Expanded Access Program (EAP) and is intended for patients with serious or life-threatening conditions, who do not have any viable or available treatment options, and are unable to participate in ongoing clinical trials," Regeneron said in a statement. The plan is to enroll 2,000 patients in early studies of the treatment."After months of incredibly hard work by our talented team, we are extremely gratified to see that Regeneron's antibody cocktail REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron. "The greatest treatment benefit was in patients who had not mounted their own effective immune response, suggesting that REGN-COV2 could provide a therapeutic substitute for the naturally-occurring immune response. These patients were less likely to clear the virus on their own, and were at greater risk for prolonged symptoms.The treatment is a combination of two monoclonal and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19, the company said.“The two potent, virus-neutralizing antibodies that form REGN-COV2 bind non-competitively to the critical receptor binding domain of the virus's spike protein, which diminishes the ability of mutant viruses to escape treatment and protects against spike variants that have arisen in the human population, as detailed in Science.” Regeneron said in a statement. “Preclinical studies have shown that REGN-COV2 reduced the amount of virus and associated damage in the lungs of non-human primates.”According to Regeneron, the treatment has been tried on hospitalized and non-hospitalized patients and as a preventative for those who have had close contact with coronavirus patients. So far, the drug has been particularly promising for non-hospitalized patients.Regeneron said the treatment reduces the viral load from the coronavirus, and boosts the body’s immune response to the virus. 2890

President Donald Trump was infuriated after it quickly leaked that he had been directly instructed by his national security advisers in briefing materials not to congratulate Russian President Vladimir Putin on his recent election victory during their call Tuesday morning, a source familiar with the President's thinking said.Trump was fuming Tuesday night, asking his allies and outside advisers who they thought had leaked the information, noting that only a small group of staffers have access to those materials and would have known what guidance was included for the Putin call, the source said.According to the source, the incident resurfaces his long-held belief there are individuals inside his administration -- especially in the national security realm -- who are actively working to undermine him. 817

Rep. Kevin McCarthy was elected House minority leader Wednesday, according to members of Congress in the closed-door meeting where the elections took place, meaning the California Republican will lead House GOP members after Speaker Paul Ryan leaves Capitol Hill at the end of his term in January.The vote was 159-43.With Ryan headed for the exits, McCarthy, the current No. 2 House Republican, was long viewed as the heavy favorite to become minority leader in the new Congress, the highest-ranking GOP leadership post with Republicans in the minority after losing control of the House of Representatives in the 2018 midterms.McCarthy faced a long-shot challenge from Rep. Jim Jordan, the co-founder of the conservative Freedom Caucus, but the California Republican is expected to prevail in his bid to become minority leader. Ryan announced in April that he would not seek re-election and has endorsed McCarthy, the House majority leader for the past four years, to be his successor.Trump and McCarthy have spoken about leadership races recently, territory that Presidents usually avoid so not as to seem like they're alienating members of their own party. In private conversations, Trump has pushed for Jordan and another close conservative ally -- Rep. Mark Meadows of North Carolina -- to have the top Republican positions on key committees, according to a source familiar. McCarthy doesn't dole out those positions-- that's for the House GOP Steering Committee -- but plenty of people on the Steering Committee are loyal to McCarthy and would heed his word. As of Wednesday afternoon it was not clear where Jordan or Meadows would land.A separate source confirmed to CNN that Jordan is interested in ranking member position on Judiciary Committee in order to check Democratic investigations that will be led by Rep. Jerry Nadler of New York. Politico first reported Wednesday that Trump has privately pushed McCarthy to make a deal with Jordan.McCarthy has also positioned himself as a close ally of Trump and a leader who can help Republicans win back control of Congress. In a letter announcing his bid for minority leader, he wrote, "We need to lay the groundwork to regain the majority so that we can continue working alongside President Trump to fulfill our promise to fundamentally change Washington. I helped build a majority from a deeper hole than this and I have what it takes to do it again."Jordan, meanwhile, has pitched himself as a leader who could help defend the President against what is expected to be aggressive Democratic-led oversight efforts."You stand up for the truth. You stand up and defend the White House and the President," Jordan told CNN in a recent interview after being asked how House Republicans can counter a Democratic majority pursuing oversight of the President and the administration.Rep. Scott Perry of Pennsylvania, a member of the Freedom Caucus, said on Tuesday that he plans to vote for Jordan and argued that House Republicans need a change over the status quo if they want to win back the majority."Unless we want to keep on losing races then we ought to consider doing something different than what we've been doing," Perry said. "I don't want to keep doing the same dumb things that we're doing and lose races."Whoever wins out as minority leader will become the most visible face of opposition to the incoming Democratic majority. The next minority leader will also have to decide whether and when the GOP minority might work to find common ground with Democrats and could also come under increased scrutiny from the President as the administration itself goes under a microscope in the new Democrat-controlled Congress.The leadership election comes as incoming freshmen, fresh off of their election wins last week, are in town for new member orientation. Dan Meuser, a member-elect from Pennsylvania, said he's spoken with both men over the weekend about their plans for the next two years, and he hasn't made a decision."I've gotten close with Kevin McCarthy. I think very highly of him. I think he's a very good conservative, showed up a lot of leadership. He certainly earned the position," Meuser told reporters on Tuesday. "On the same note, I think Jim Jordan is a smart, tough, focused individual. So I respect him as well. We'll see over the next couple of days."Next in line for the GOP leadership hierarchy in the new Congress is Rep. Steve Scalise, the current No. 3 House Republican, who is vying for the position of minority whip in the new Congress. Scalise, as majority whip, gained a higher national profile after he was injured last year in a shooting during a Republican congressional baseball practice. Scalise is not facing a challenge for the position.Rep. Liz Cheney, the daughter of former Vice President Dick Cheney, is running unopposed for the position of Republican conference chair, the third-ranking position in the leadership hierarchy with Republicans in the minority. The position is currently held by Rep. Cathy McMorris Rodgers, but she is not seeking re-election to the post.This story has been updated and will continue to update with additional developments.The-CNN-Wire 5173

President-elect Joe Biden has picked an experienced but not widely known state regulator, Michael Regan of North Carolina, to lead the Environmental Protection Agency. Regan is head of North Carolina’s environmental agency. He was one of several contenders whose name emerged only in recent days. Biden’s pick was confirmed Thursday by a person familiar with the selection process who was not authorized the discuss the matter publicly before the official announcement and spoke on condition of anonymity.According to the Washington Post, if confirmed, Regan would be the first Black man to run the agency. 614

来源：资阳报